| 1 |
Selvaraju V, Babu JR, Geetha T. Salivary C-Reactive Protein as a Biomarker and Implications for Diabetes. Biomarkers in Diabetes 2023. [DOI: 10.1007/978-3-031-08014-2_17] [Reference Citation Analysis]
|
| 2 |
Berezin AA, Fushtey IM, Pavlov SV, Berezin AE. Predictive value of serum irisin for chronic heart failure in patients with type 2 diabetes mellitus. Mol Biomed 2022;3:34. [DOI: 10.1186/s43556-022-00096-x] [Reference Citation Analysis]
|
| 3 |
Berezin AA, Lichtenauer M, Boxhammer E, Stöhr E, Berezin AE. Discriminative Value of Serum Irisin in Prediction of Heart Failure with Different Phenotypes among Patients with Type 2 Diabetes Mellitus. Cells 2022;11:2794. [DOI: 10.3390/cells11182794] [Reference Citation Analysis]
|
| 4 |
Berezin AA, Fushtey IM, Berezin AE. Discriminative Utility of Apelin-to-NT-Pro-Brain Natriuretic Peptide Ratio for Heart Failure with Preserved Ejection Fraction among Type 2 Diabetes Mellitus Patients. JCDD 2022;9:23. [DOI: 10.3390/jcdd9010023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Selvaraju V, Babu JR, Geetha T. Salivary C-Reactive Protein as a Biomarker and Implications for Diabetes. Biomarkers in Diabetes 2022. [DOI: 10.1007/978-3-030-81303-1_17-1] [Reference Citation Analysis]
|
| 6 |
Lebedev DA, Lyasnikova EA, Vasilyeva EY, Likhonosov NP, Sitnikova MY, Babenko AY. Association between Markers of Fibrosis and Heart Failure Incidence in Patients with Type 2 Diabetes Mellitus. J Diabetes Res 2021;2021:9589185. [PMID: 34778465 DOI: 10.1155/2021/9589185] [Reference Citation Analysis]
|
| 7 |
Hao W, Li N, Mi C, Wang Q, Yu Y. Salidroside attenuates cardiac dysfunction in a rat model of diabetes. Diabet Med 2021;:e14683. [PMID: 34467560 DOI: 10.1111/dme.14683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Kumric M, Ticinovic Kurir T, Borovac JA, Bozic J. Role of novel biomarkers in diabetic cardiomyopathy. World J Diabetes 2021; 12(6): 685-705 [PMID: 34168722 DOI: 10.4239/wjd.v12.i6.685] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 9 |
Lichtenauer M, Jirak P, Paar V, Sipos B, Kopp K, Berezin AE. Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication. Applied Sciences 2021;11:4397. [DOI: 10.3390/app11104397] [Reference Citation Analysis]
|
| 10 |
Naveed H, Elshafeey A, Al-Ali D, Janjua E, Nauman A, Kawas H, Kaul R, Saed Aldien A, Elshazly MB, Zakaria D. The Interplay Between the Immune System, the Renin-Angiotensin-Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID-19: A Systematic Review. J Clin Pharmacol 2021;61:987-1000. [PMID: 33635546 DOI: 10.1002/jcph.1852] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Rojas-Humpire R, Olarte-Durand M, Medina-Ramirez S, Gutierrez-Ajalcriña R, Canaza JF, Huancahuire-Vega S. Insulin Resistance Indexes as Biomarkers of Lifetime Cardiovascular Risk among Adults from Peru. J Nutr Metab 2021;2021:6633700. [PMID: 33833874 DOI: 10.1155/2021/6633700] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Bilchenko A, Vysotska К. INTERRELATIONS BETWEEN GROWTH DIFFERENTIATION FACTOR 15, P-SELECTIN AND GALECTIN-3 AND CLINICAL COURSE IN PATIENTS WITH ARTERIAL HYPERTENSION AND TYPE 2 DIABETES MELLITUS. EUREKA: Health Sciences 2020;5:3-9. [DOI: 10.21303/2504-5679.2020.001409] [Reference Citation Analysis]
|
